MEX-CD1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MEX-CD1, covering 2026-01-22 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury [Phase 1, Phase 2]